Skip to main content
. 2020 Nov 12;11:564792. doi: 10.3389/fgene.2020.564792

Table 2.

Five breast cancer cell lines that are available multi-omics data before drug treatment with lapatinib sensitivity and time-series gene expression data after drug treatment.

Cell line Molecular sub-subtype IC50(μM)
BT-549 Basal B 2.02
T-47D Luminal 2.90
MCF7 Luminal 3.04
MDA-MB-468 Basal A 3.77
MDA-MB-231 Basal B 6.50